Journal of Pain and Symptom Management
Volume 38, Issue 6 , Pages 894-902 , December 2009

Genetic and Nongenetic Covariates of Pain Severity in Patients with Adenocarcinoma of the Pancreas: Assessing the Influence of Cytokine Genes

  • Cielito C. Reyes-Gibby, DrPH

      Affiliations

    • Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
    • Corresponding Author InformationAddress correspondence to: Cielito C. Reyes-Gibby, DrPH, Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, 1155 Pressler Street, Unit 1340, Houston, TX 77030-4009, USA.
  • ,
  • Sanjay Shete, PhD

      Affiliations

    • Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Sriram Yennurajalingam, MD

      Affiliations

    • Supportive Care Center, Department of Palliative Care and Rehabilitation Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Marsha Frazier, PhD

      Affiliations

    • Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Eduardo Bruera, MD

      Affiliations

    • Supportive Care Center, Department of Palliative Care and Rehabilitation Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Razelle Kurzrock, MD

      Affiliations

    • Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Christopher H. Crane, MD

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • James Abbruzzese, MD

      Affiliations

    • Department of Gastroinstestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Douglas Evans, MD

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
  • ,
  • Margaret R. Spitz, MD

      Affiliations

    • Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

,Accepted 23 April 2009.

References 

  1. Watkins LR, Wiertelak EP, Goehler LE, et al. Characterization of cytokine-induced hyperalgesia. Brain Res. 1994;654:15–26
  2. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57:1011–1026
  3. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63:289–302
  4. Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA. 1999;96:7710–7713
  5. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol. 2003;521:1–21
  6. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257:139–155
  7. Oh SB, Tran PB, Gillard SE, et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001;21:5027–5035
  8. Reyes-Gibby CC, Spitz M, Wu X, et al. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007;16:2745–2751
  9. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82:263–274
  10. Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res. 2004;13:1369–1379
  11. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905
  12. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  13. Vilaseca I, Chen AY, Backscheider AG. Long-term quality of life after total laryngectomy. Head Neck. 2006;28:313–320
  14. National Cancer Institute, Cancer Genome Anatomy Project SNP500 Cancer Database. 2007. Available from: http://snp500cancer.nci.nih.gov.
  15. Benedetti C, Brock C, Cleeland C, et al. NCCN practice guidelines for cancer pain. Oncology (Williston Park). 2000;14:135–150
  16. Wacholder S, Chanock S, Garcia-Closas M, El GL, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–442
  17. Puthothu B, Krueger M, Heinze J, Forster J, Heinzmann A. Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy. 2006;4:2
  18. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J. 2002;11:62–66
  19. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004;101:2727–2736
  20. Cunha TM, Verri WA, Silva JS, et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA. 2005;102:1755–1760
  21. Ribeiro RA, Vale ML, Thomazzi SM, et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol. 2000;387:111–118
  22. Kotani N, Kudo R, Sakurai Y, et al. Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am J Med. 2004;116:318–324
  23. Bessler H, Shavit Y, Mayburd E, Smirnov G, Beilin B. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neurosci Lett. 2006;404:154–158
  24. Honore P, Wade CL, Zhong C, et al. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res. 2006;167:355–364
  25. McCulley MC, Day IN, Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2004;124:50–53
  26. Milligan ED, Soderquist RG, Malone SM, et al. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol. 2006;2:293–308
  27. Milligan ED, Sloane EM, Langer SJ, et al. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain. 2006;126:294–308
  28. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature. 2007;447:655–660
  29. Reyes-Gibby CC, Wu X, Spitz M, et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol. 2008;9:777–785

 This work was supported by Public Health Service grants CA109043 and CA128069 from the National Cancer Institute. Patient consent and acquisition of blood specimens were supported by the Various Donor Fund for Pancreatic Cancer Research and National Institutes of Health grant CA101936 (SPORE in Pancreatic Cancer), The Texas Medical Center Genetics Consortium, and the Center for Clinical and Translational Sciences of the University of Texas Health Science Center at Houston.

PII: S0885-3924(09)00597-1

doi: 10.1016/j.jpainsymman.2009.04.019

Journal of Pain and Symptom Management
Volume 38, Issue 6 , Pages 894-902 , December 2009